IP Library Granted Patent US 12,484,607
Granted Patent B2
US 12,484,607 · App. 17/182,676 · Granted Dec 2, 2025

Methods and formulations promoting tissue/organ regeneration, longevity and healthspan

Inventors: Valter D. Longo (Play del Rey, CA); Chia-Wei Cheng (Los Angeles, CA); Sebastian Brandhorst (Redondo Beach, CA); Min Wei (West Covina, CA); Todd E. Morgan (Manhattan Beach, CA)
Assignee: UNIVERSITY OF SOUTHERN CALIFORNIA
A23L33/40A23L29/37A23L33/115A23L33/15A23L33/155A23L33/16A23L33/17A23L33/175A23L33/30A61K45/00A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,484,607
App. No.
17/182,676
Granted
Dec 2, 2025
Kind
B2
Abstract

A method includes a step of identifying a subject in need of diet modification; and administering a first diet to the subject for a first time period. The first diet provides 4.5 to 7 kilocalories per pound of subject for a first day and 3 to 5 kilocalories per pound of subject per day for a second to fifth day of the first diet. The first diet includes less than 30 g of sugar on the first day; less than 20 g of sugar on the second to fifth days; less than 28 g of proteins on the first day; less than 18 g of proteins on days the second to fifth days; 20 to 30 grams of monounsaturated fats on the first day; 10 to 15 grams of monounsaturated fats on the second to fifth days; and between 6 and 10 grams of polyunsaturated fats on the first day.

Claims (19)

1 . A method comprising:

identifying a subject in need of weight reduction having a BMI greater than 30; and

administering a first diet to the subject for a first time period of 5 days, the first diet providing 4.5 to 7 kilocalories per pound of subject for a first day and 3 to 5 kilocalories per pound of subject per day for a second to fifth day of the first diet, the first diet providing the subject with at most 50% of the subject's normal caloric intake with at least 50% of the kilocalories being derived from fat, first diet may be administered to the subject with from 700 to 1200 kcal/day, wherein at least the first diet including:

less than 30 g of sugar on the first day;

less than 20 g of sugar on the second to fifth days;

less than 28 g of proteins on the first day;

less than 18 g of proteins on days the second to fifth days;

20 to 30 grams of monounsaturated fats on the first day;

10 to 15 grams of monounsaturated fats on the second to fifth days;

between 6 and 10 grams of polyunsaturated fats on the first day;

3 to 5 grams of polyunsaturated fats on the second to fifth days;

less than 12 g of saturated fats on the first day;

less than 6 grams of saturated fats on the second to fifth days; and

12 to 25 grams of glycerol per day on the second to fifth days; wherein the first diet is provided as soups/broths, soft drinks, nut bars and supplements; and

measuring blood glucose concentration in the subject.

2 . The method of claim 1 further comprising administering a second diet for a second time period to the subject, the second diet providing a subject's normal diet and an overall calorie consumption that is within 10 percent of a subject's normal calorie consumption for 25 to 26 days following the first diet.

3 . The method of claim 2 wherein the combination of the first diet and the second diet provides the subject with a total number of calories within 10 percent of the subject's normal caloric intake.

4 . The method of claim 1 wherein the first diet includes at least 50% of the daily recommended amount of dietary fiber on all days.

5 . The method of claim 1 wherein level of IGF-I decreases and a level of IGFBP1 increases.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2025
From: L-NUTRA INC.
To: THE UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 071867/0249 →
CONFIRMATORY LICENSE Recorded Nov 2, 2023
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065431/0393 →
Continuity (6)
Continuation 15297672 · Oct 19, 2016
Continuation 14060494 · Oct 22, 2013
Provisional Application 61746787 · Dec 28, 2012
Provisional Application 61736308 · Dec 12, 2012
Provisional Application 61716676 · Oct 22, 2012
Related Publication 20210177032A1 · Jun 17, 2021
References Cited (148)
US 8211700B2 · Longo · 2012 [cited by applicant]
US 8728815B2 · Longo · 2014 [cited by applicant]
US 8821915B2 · Cincotta · 2014 [cited by examiner]
US 8865646B2 · Longo · 2014 [cited by applicant]
US 20060063827A1 · Yu et al. · 2006 [cited by applicant]
US 20070116802A1 · Germano · 2007 [cited by applicant]
US 20080038367A1 · Saloum · 2008 [cited by applicant]
US 20100004309A1 · Longo · 2010 [cited by examiner]
US 20110118528A1 · Longo · 2011 [cited by examiner]
US 20130045215A1 · Longo et al. · 2013 [cited by applicant]
US 20130316948A1 · Longo · 2013 [cited by applicant]
US 20140112909A1 · Longo et al. · 2014 [cited by applicant]
US 20140328863A1 · Longo · 2014 [cited by applicant]
US 20150133370A1 · Longo · 2015 [cited by applicant]
EP 1356252A · 1974 [cited by applicant]
JP 2004518647A · 2004 [cited by applicant]
JP 2010513278A · 2010 [cited by applicant]
WO 0247702A1 · 2002 [cited by applicant]
WO 2008076278A2 · 2008 [cited by applicant]
WO 2009070378A1 · 2009 [cited by applicant]
WO 2010075511A1 · 2010 [cited by applicant]
WO 2011050302A2 · 2011 [cited by applicant]
WO 2012109353A2 · 2012 [cited by applicant]
WO 2012113415A1 · 2012 [cited by applicant]
WO 2014066426A1 · 2014 [cited by applicant]
WO 2014127000A2 · 2014 [cited by applicant]
Mayo Clinic. “Obesity—Symptoms and causes.” Mayo Clinic, www.mayoclinic.org/diseases-conditions/obesity/symptoms-causes/syc-20375742 (Year: 2023). [cited by examiner]
Wirtshafter et al. Body Weight Reduction by Long-term Glycerol Treatment. Science 198, 1271-1274 (1977) (Year: 1977). [cited by examiner]
Veira, F. A. et al., “Skin healing and scale regeneration in fed and unfed sea bream, [cited by applicant]
Wang, J. et al., “Caloric restriction attenuates B-amyloid neuropathology in a mouse model of Alzheimer's disease”, The FASEB Journal, 2005, pp. 1-18. [cited by applicant]
Wei, M. et al., “Tor1/Sch9-Regulated Carbon Source Substitution Is as Effective as Calorie Restriction in Life Span Extension”, May 2009, pp. 1-15, vol. 5 Issue 5. [cited by applicant]
Williams, M. D. et al., “Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care”, 2004, pp. R291-R298. [cited by applicant]
Wu, P. et al., “Calorie restriction ameliorates neurodegenerative phenotypes in forebrain-specific presenilin-1 and presenilin-2 double knockout mice”, Neurobiology of Aging, 2007, pp. 1502-1511. [cited by applicant]
Yahata, T. et al., “Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells”, Blood, Sep. 15, 2011, pp. 2941-2950, vol. 118, No. 11. [cited by applicant]
Yamamizu, K. et al., “PKA/CREB Signaling Triggers Initiation of Endothelial and Hematopoietic Cell Differentiation via Etv2 Induction,” Stem Cells, 2012, pp. 687-696. [cited by applicant]
Yamamoto, H. et al., “Enzymatic Conversion of IGF-I to des(1-3)IGF-I in Rat Serum and Tissues: a Further Potential Site of Growth Hormone Regulation of IGF-I Action,” J. of Endocrinology, 1995, pp. 141-148. [cited by applicant]
Yilmaz, O.H. et al., “mTORC1in the Paneth Cell Niche Couples Intestinal Stem Cell Function to Calorie Intake,” Nature, 2012, pp. 1-16. [cited by applicant]
Young, S.N., “Behavorial Effects of Dietary Neurotransmitter Precursors: Basic and Clinical Aspects,” Neuroscience and Biobehavioral Reviews, 1996, pp. 313-323, v. 20, n. 2. [cited by applicant]
Zaman, S. et al., “How [cited by applicant]
Zhang, S. et al., “CD200-CD200R Dysfunction Exacerbates Microglial Activiation and Dopaminergic Neurodegeneration in a Rat Model of Parkinson's Diseases,” J. of Neuroinflammation, 2011, pp. 1-12. [cited by applicant]
Japanese Office Action dated Mar. 5, 2019 for Japanese Appn. No. 2015-538145 (with English Summary), 11 pages total. [cited by applicant]
Japanese Notice of Rejection dated Jan. 22, 2020 for Japanese Appn. No. 2018-076600 (with English Machine Translation), 5 pages total. [cited by applicant]
Office Action dated Apr. 1, 2020 for U.S. Appl. No. 15/297,672, filed Oct. 19, 2016, 21 pages total. [cited by applicant]
Final Office Action dated Apr. 1, 2020 for U.S. Appl. No. 15/297,672, filed Oct. 19, 2016, 20 pages total. [cited by applicant]
Adam, G.B. et al., “Therapeutic Targeting of a Stem Cell Niche,” Nature Biotechnology, 2007, pp. 238-243, v. 25, No. 2. [cited by applicant]
Bartke, A. et al., “Somatotropic Signaling: Trade-Offs Between Growth, Reproductive Development, and Longevity,” Physiol. Rev. 93, 2013, pp. 571-598. [cited by applicant]
Bedford, P. et al., “The Level of DNA Interstrand Crosslinking in Bone Marrow Parallels the Extent of Myelosuppression in Mice Treated with Four Chloroethylnitrosoureas”, J. of Cancer Research and Clinical Oncology 108,… [cited by applicant]
Bobick, B.E. et al., “The Intermediate Filament Vimentin Regulates Chondrogenesis of Adult Human Bone marrow-Derived Multipotent Progenitor Cells,” J. of Cellular Biochemistry, 109, pp. 265-276 (2010). [cited by applicant]
Bokov, A.F. et al., “Does Reduced IGF-1R Signaling in Igfr +/− Mice Alter Aging,” PLoS One, 2011, 10 pgs. [cited by applicant]
Bondolfi, L. et al., “Impact of Age and Caloric Restriction on Neurogenesis in the Dentate Gyrus of C57BL/6 Mice”, Neurobiology of Aging, 2004, pp. 333-340. [cited by applicant]
Brown-Borg, H. M. et al., “Dwarf Mice and the Ageing Process”, Nature, Nov. 7, 1996, p. 33. [cited by applicant]
Carro E., et al., “Circulating Insulin-Like Growth Factor I Mediates Effects of Exercise on the Brain”, The Journal of Neuroscience, Apr. 15, 2000, pp. 2926-2933. [cited by applicant]
Carro E., et al., “Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?”, Expert Rev. Neurotherapeutics, 2004, pp. 79-86. [cited by applicant]
Carro E., et al., “Serum Insulin-like growth factor I regulates brain amyloid-levels”, Nature Medicine, Dec. 2002, pp. 1390-1397, vol. 8 No. 12. [cited by applicant]
Carroll, J.C. et al., “Continuous and Cyclic Progesterone Differentially Interact with Estradiol in the Regulation of Alzheimer-Like Pathology in Female 3xTransgenic-Alzheimer's Disease Mice”, Endocrinology, Jun. 2010, … [cited by applicant]
Centrum™ dietary supplement MSDS, https://www.pfizer.com/sites/default/files/products/material_safety_data/WC00006.pdf dated Apr. 1, 2009, retrieved from the internet Nov. 25, 2018 (Centrum™). [cited by applicant]
Chen, J. et al., “Hematopoietic senescence is postponed and hematopoietic stem cell function is enhanced by dietary restriction”, Experimental Hematology, 2003, pp. 1097-1103. [cited by applicant]
Cohen, E. et al., “Reduced IGF-1 Signaling Delays Age-associated Proteotoxicity in Mice”, 2009, pp. 1-23. [cited by applicant]
Crowe, F.L. et al., “The Association between Diet and Serum Concentrations of IGF-I, IGFBP-1, IGFBP-2, and GFBP-3 in the European Prospective Investigation into Cancer and Nutrition,” Cancer Epidemiol Biomarkers Prev., … [cited by applicant]
De Coppi, P. et al., “Isolation of amniotic stem cell lines with potential for therapy”, Nature Biotechnology, 2007, pp. 100-106. [cited by applicant]
De Leon, M. J. et al., “Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment”, 2006, pp. 394-401. [cited by applicant]
Ditadi, A. et al., “Human and murine amniotic fluid c-Kit+Lin-cells display hematopoietic activity”, Blood, Apr. 23, 2009, pp. 3953-3960, vol. 113, No. 17. [cited by applicant]
Ertl, R. P. et al., “Effects of dietary restriction on hematopoietic stem-cell aging are genetically regulated”, Blood, Feb. 1, 2008, pp. 1709-1716, vol. 111, No. 3. [cited by applicant]
Fabrizio, P. et al., “Regulation of Longevity and Stress Resistance by Sch9 in Yeast”, Science, Apr. 13, 2001, pp. 288-290, vol. 292. [cited by applicant]
Fabrizio, P. et al., “SOD2 Functions Downstream of Sch9 to Extend Longevity in Yeast”, Genetics, Jan. 2003, pp. 35-46. [cited by applicant]
Faherty, S. et al., “Self-renewal and differentiation of mouse embryonic stem cells as measured by Oct4 expressions: the role of the cAMP/PKA pathway”, 2007, pp. 37-47. [cited by applicant]
Fontan-Lozano, A et al., “Molecular Bases of Caloric Restriction Regulation of Neuronal Synaptic Plasticity”, 2008, pp. 167-177. [cited by applicant]
Fontana, L. et al., “Extending Healthy Life Span—From Yeast to Humans”, 2010, pp. 321-326. [cited by applicant]
Fontana, L. et al., “Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans”, Oct. 2008, pp. 1-14. [cited by applicant]
Gerald et al., “Alzheimer's Disease Market: Hope Deferred,” Nature Reviews Drug Discovery, 2013; 12:19-20. [cited by applicant]
Gietzen, D. W. et al., “Mechanisms of Food Intake Repression in Indispensable Amino Acid Deficiency”, 2007, pp. 63-78. [cited by applicant]
Goedert, M. et al., “Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205”, Neuroscience Letters 189, 1995, pp. 167-170. [cited by applicant]
Gonzalez, G. A. et al., “Cyclic AMP Stimulates Somatostatin Gene Transcription by Phosphorylation of CREB at Serine 133”, Cell, Nov. 17, 1989, pp. 675-680, vol. 59. [cited by applicant]
Guevara-Aguirre, J. et al., Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, 2011, pp. 1-9. [cited by applicant]
Gulinello, M. et al., “Validation of a 2-day water maze protocol in mice”, Jan. 23, 2009, pp. 220-227. [cited by applicant]
Halagappa, V. K. et al., “Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease”, Neurobiology of Disease, 2007, pp. 212-220. [cited by applicant]
Hofmeister, C.C. et al., “Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche”, 2007, pp. 11-23. [cited by applicant]
Holzenberger, M. et al., “IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice”, Nature, Jan. 9, 2003, pp. 182-187, vol. 421. [cited by applicant]
Hwang, D. L. et al., “Quantitative Ontogeny of Murine Insulin-Like Growth Factor (IGF)-I, IGF-binding Protein-3 and the IGF-related Acid-labile Subunit”, Feb. 2008, pp. 65-74. [cited by applicant]
Keno, Y. et al., “Reduced Incidence and Delayed Occurrence of Fatal Neoplastic Diseases in Growth Hormone Receptor/Binding Protein Knockout Mice”, 2009, pp. 522-529, vol. 64A, No. 5. [cited by applicant]
Ito, K. et al., “Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells”, 2006, pp. 446-451. [cited by applicant]
Kenyon, C., “A Conserved Regulatory System for Aging”, Cell, 2001, pp. 165-168, vol. 105. [cited by applicant]
Kenyon, C., “The Plasticity of Aging: Insights from Long-Lived Mutants”, Cell, 2005, pp. 449-460, vol. 120. [cited by applicant]
Ketelslegers, J. M. et al., “Nutritional Regulation of Insulin-Like Growth Factor-I”, Metabolism, 1995, pp. 50-57, vol. 44 No. 10. [cited by applicant]
“Keto Adapted”, downloaded from https://mariamindbodyhealth.com/no-bake-energy-bars/, published online Jul. 18, 2010, 42 pgs. [cited by applicant]
Kim, S. Y. et al., “PAGE: Parametric Analysis of Gene Set Enrichment”, 2005, pp. 1-12. [cited by applicant]
Kinney, B. A. et al., “Evidence that age-induced decline in memory retention is delayed in growth hormone resistant GH-R-KO (Laron) mice”, Physiology & Behavior, 2001, pp. 653-660. [cited by applicant]
Kirschner, L. S. et al., “Mouse models of altered protein kinase A signaling”, Endocrine-Related Cancer, 2009, pp. 773-793. [cited by applicant]
Kitazawa, M. et al., “Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease”, The Journal of Neuroscience, Sep. 28… [cited by applicant]
Kofman, A. E. et al., “Rapamycin increases oxidative stress response gene expression in adult stem cells”, Aging, 2012, pp. 279-289. [cited by applicant]
Kolosova, N. G. et al., “Prevention of Age-Related Macular Degeneration-Like Retinopathy by Rapamycin in Rats”, The American Journal of Pathology, Aug. 2012, pp. 472-477, vol. 181, No. 2. [cited by applicant]
Kucia, M. et al., “A population of very small embryonic-like (VSEL) CXCR4+SSEA-1+Oct-4+ stem cells identified in adult bone marrow”, Leukemia, 2006, pp. 857-869. [cited by applicant]
Kucia, M. J. et al., “Evidence That Very Small Embryonic-Like Stem Cells Are Mobilized into Peripheral Blood”, Stem Cells, 2008, pp. 2083-2092. [cited by applicant]
Kuret, J. et al., “Mutagenesis of the Regulatory Subunit of Yeast cAMP-dependent Protein Kinase”, Jul. 5, 1988, pp. 9149-9154. [cited by applicant]
Pawlowski, K.M. et al., “Growth Hormone Receptor (ghr) RNAI Decreases Proliferation and Enhances Apoptosis in CMT-U27 Canine Mammary Carcinoma Cell Line,” Veterinary and Comparative Oncology, 10, 1, pp. 2-15 (2011). [cited by applicant]
Notice of Reasons of Refusal dtd Mar. 29, 2022 for Japanese Appn. No. 2018-76600, 9 pgs (includes English Translation). [cited by applicant]
Lee, C. et al., “Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy”, Feb. 8, 2012, pp. 1-16. [cited by applicant]
Lee, C. et al., “Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients”, Oncogene, 2011, pp. 3305-3316. [cited by applicant]
Lee, C. et al., “Reduced Levels of IGF-I Mediate Differential Protection of Normal and Cancer Cells in Response to Fasting and Improve Chemotherapeutic Index”, Jan. 11, 2012, pp. 1564-1572. [cited by applicant]
Lee, Y-J. et al., “Adenovirus expressing shRNA to IGF-1R enhances the chemosensitivity of lung cancer cell lines by blocking IGF-1 pathway,” Lung Cancer (2007), 55, pp. 279-286. [cited by applicant]
Longo, V.D. et al., “Calorie Restriction and Cancer Prevention: Metabolic and Molecular Mechanisms,” Trends in Pharmacological Sciences, v. 31, n. 2, 2010, pp. 89-98. [cited by applicant]
Longo, V. D. et al., “Evolutionary Medicine: From Dwarf Model Systems to Healthy Centenarians”, Science, 2003, pp. 1342-1346. [cited by applicant]
Longo, V. D. et al., “Human Bcl-2 Reverses Survival Defects in Yeast Lacking Superoxide Dismutase and Delays Death of Wild-Type Yeast”, The Journal of Cell Biology, Jun. 30, 1997, pp. 1581-1588, vol. 137 No. 7. [cited by applicant]
Luchsinger, J. A. et al., “Caloric Intake and the Risk of Alzheimer Disease”, Arch Neurol, Aug. 2002, pp. 1258-1263, vol. 59. [cited by applicant]
Mackall, C. L. et al., “Lymphocyte Depletion During Treatment With Intensive Chemotherapy for Cancer”, Blood, Oct. 1, 1994, pp. 2221-2228, vol. 84, No. 7. [cited by applicant]
Martin, B. et al., “Caloric restriction and intermittent fasting: Two potential diets for successful brain aging”, Aug. 2006, pp. 332-353. [cited by applicant]
Masternak, M. M. et al., “Insulin Sensitivity as a Key Mediator of Growth Hormone Actions on Longevity”, 2009, pp. 516-521, vol. 64A No. 5. [cited by applicant]
Matsumoto, K. et al., “Stepwise Development of Hematopoietic Stem Cells from Embryonic Stem Cells”, Mar. 2009, pp. 1-10, vol. 4 Issue 3. [cited by applicant]
Mattson, M. P. et al., “Energy Intake, Meal Frequency, and Health: A Neurobiological Perspective”, 2005, pp. 237-260. [cited by applicant]
Mauch, P. et al., “Hematopoietic Stem Cell Compartment: Acute and Late Effects of Radiation Therapy and Chemotherapy”, 1995, pp. 1319-1339, vol. 31 No. 5. [cited by applicant]
Mouton, P. R. et al., “Caloric restriction attenuates amyloid deposition in middle-ages APP/ PS1 mice”, Oct. 30, 2009, pp. 184-187. [cited by applicant]
Nimeth, K. T. et al., Stem Cell Dynamics During Growth, Feeding, and Starvation in the Basal Flatworm [cited by applicant]
Oddo, S. et al., “Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease”, Neurobiology of Aging, 2003, pp. 1063-1070. [cited by applicant]
Otis, M. et al., “Angiotensin II Stimulates Protein Synthesis and Inhibits Proliferation in Primary Cultures of Rat Adrenal Glomerulosa Cells”, The Endocrine Society, 2005, pp. 633-642. [cited by applicant]
Pang, Q., “HSCs: stressing out over ROS”, blood, Sep. 15, 2011, pp. 2932-2934, vol. 118, No. 11. [cited by applicant]
Parrella, E. et al., “Insulin/IGF-I and Related Signaling Pathways Regulate Aging in Nondividing Cells: from Yeast to the Mammalian Brain”, TheScientificWorld, 2010, pp. 161-177. [cited by applicant]
Patel, N. V. et al., “Caloric restriction attenuates AB-deposition in Alzheimer transgenic models”, Neurobiology of Aging, 2005, pp. 995-1000. [cited by applicant]
Polak, D. J., “Regenerative medicine. Opportunities and challenges: a brief overview”, J.R. Soc. Interface, 2010, pp. S777-S781, 7 Suppl. 6. [cited by applicant]
Rafalski, V. A. et al., “Energy metabolism in adult neural stem cell fate”, Progress in Neurobiology, 2011, pp. 182-203. [cited by applicant]
Raffaghello, L. et al., “Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy”, Jun. 17, 2008, pp. 8215-8220, vol. 105 No. 24. [cited by applicant]
Ramos, F. J. et al., “Rapamycin Reverses Elevated mTORC1 signaling in Lamin A/C-Deficient Mice, Rescued Cardiac and Skeletal Muscle Function, and Extends Survival”, Sci Transl Med., 2012, pp. 1-25. [cited by applicant]
Rando, T. A. et al., “Aging, Rejuvenation, and Epigenetic Reprogramming: Resetting the Aging Clock”, Cell, 2012, pp. 46-57. [cited by applicant]
Ratajczak, J. et al., “Adult Murine Bone Marrow-Derived Very Small Embryonic-Like Stem Cells (VSELs) Differentiate Into the Hematopoietic Lineage After Co-Culture Over OP9 Stromal Cells”, 2011, pp. 225-237. [cited by applicant]
Ratajczak, J. et al., “Hematopoietic Differentiation of Umbilical Cord Blood-Derived Very Small Embryonic/Epiblast-Like Stem Cells”, Leukemia, 2011, pp. 1278-1285. [cited by applicant]
Ratajczak, J. et al., “Higher number of stem cells in bone marrow of circulating Igf-1 level low Laron dwarf mice—novel view on Igf-1, stem cells and aging”, Leukemia, 2011, pp. 729-733. [cited by applicant]
Ratajczak, M. Z. et al., “A novel insight into aging: are there pluripotent very small embryonic-like stem cells (VSELs) in adult tissues overtime depleted in an Igf-1-dependent manner?”, Aging, Nov. 2010, pp. 875-883, … [cited by applicant]
Ratajczak, M. Z. et al., “Very Small Embryonic-Like (VSEL) Stem Cells: Purification from Adult Organs, Characterization, and Biological Significance” Stem Cell Rev., 2008, pp. 89-99. [cited by applicant]
Rinaldi, J. et al., “Structure of Yeast Regulatory Subunit: A Glimpse into the Evolution of PKA Signaling”, Structure, Nov. 10, 2010, pp. 1471-1482. [cited by applicant]
Roberson, E. D. et al., “Reducing Endogenous Tau Ameliorates Amyloid B-Induced Deficits in an Alzheimer's Disease Mouse Model”, Science, May 4, 2007, pp. 750-754, vol. 316. [cited by applicant]
Rosario, E. R. et al., “Androgens Regulate the Development of Neuropathology in a Triple Transgenic Mouse Model of Alzheimer's Disease”, The Journal of Neuroscience, Dec. 20, 2006, pp. 13384-13389. [cited by applicant]
Rubey, “Could lysine Supplementation Prevent Alzheimer's Dementia? A Novel Hypothesis,” Neuropsychiatric Disease and Treatment, 2010; 6:707-710. [cited by applicant]
Rybtsov, S. et al., “Hierarchical organization and early hematopoietic specification of the developing HSC lineage in the AGM region”, The Journal of Experimental Medicine, 2011, pp. 1305-1315, vol. 208 No. 6. [cited by applicant]
Safdie, F. M. et al., “Fasting and cancer treatment in humans: A case series report”, Aging, Dec. 2009, pp. 1-20, vol. 1 No. 12. [cited by applicant]
Sagar, J. et al., “Role of stem cells in cancer therapy and cancer stem cells: a review”, Cancer Cell International, 2007, pp. 1-11. [cited by applicant]
Salmon, A. B. et al., “Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress”, 2005, pp. E23-E29. [cited by applicant]
Sanghera, K. P. et al., “The PI3K/Akt/mTOR pathway mediates retinal progenitor cell survival under hypoxic and superoxide stress”, Molecular and Cellular Neuroscience, 2011, pp. 145-153. [cited by applicant]
Schrag, M. et al., “Hippocampus of Ames Dwarf Mice Is Resistant to B-Amyloid-Induced Tau Hyperphosphorylation and Changes in Apoptosis-Regulatory Protein Levels”, 2008, pp. 239-244. [cited by applicant]
Sharma, S. et al., “NMDA and kainate receptor expression, long-term potentiation, and neurogenesis in the hippocampus of long-lived Ames dwarf mice”, Age, 2012, pp. 609-620. [cited by applicant]
Sharma, S. et al., “Spatial memory is enhanced in long-living Ames dwarf mice and maintained following kainic acid Induced neurodegeneration”, Jun. 2010, pp. 422-435. [cited by applicant]
Sonntag, W. E. et al., “Pleiotropic Effects of Growth Hormone and Insulin-like Growth Factor (IGF)-1 on Biological Aging: Inferences From Moderate Caloric-Restricted Animals”, Journal of Gerontology, 1999, pp. B521-B538… [cited by applicant]
Suh, Y. et al., “Functionally significant insulin-like growth factor I receptor mutations in centenarians”, Mar. 4, 2008, pp. 3438-3442, vol. 105 No. 9. [cited by applicant]
Talbot, K. et al., “Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline”, The Journal of Clinical Investigation, Apr. 201… [cited by applicant]
Trommelmans, L., “Regenerative medicine. Opportunities and Challenges: a brief overview”, 2010, pp. 24-26, vol. 40 No. 6. [cited by applicant]
Trommelmans, L., “The Challenge of Regenerative Medicine,” Hastings Center Report, 2010, pp. 24-26, vol. 40, No. 6. [cited by applicant]
van Tilburg, C. M. et al., “Immune reconstitution in children following chemotherapy for haematological malignancies: a long-term follow-up”, 2010, pp. 201-210. [cited by applicant]
Vardy, E. R. et al., “Increased Circulating Insulin-like Growth Factor-1 in Late-onset Alzheimer's Disease”, Journal of Alzheimer's Disease, 2007, pp. 285-290. [cited by applicant]
Final Office Action dtd Sep. 6, 2022 for Japanese Appn. No. 2018-76600, 9 pgs (include Eng Translation). [cited by applicant]
Thissen, J.P. et al., Endocr Rev 15 (1994) , pp. 80-101 (Abstract only—2 pgs.). [cited by applicant]